CANWAY Holdings Ltd. is a Swiss holding company and one of the pioneering first movers in the European cannabis industry, with some of its subsidiaries dating back to 2016. We specialize in the acquisition, strategic investment, and long-term management of cannabis businesses across multiple jurisdictions.
Active throughout the entire cannabis value chain - including cultivation, processing, distribution, retail, and research & development - CANWAY builds and manages a diversified portfolio of innovative, high-potential companies. Our mission is to drive sustainable growth and deliver long-term value for our stakeholders in the rapidly evolving legal cannabis sector.
CANWAY is a vertically integrated cannabis company, expertly managing every step of the value chain - from breeding, cultivation, and processing to distribution and customer delivery. This integrated structure ensures full control over operations, enables consistent product quality, supports strict regulatory compliance, and allows for agile adaptation to evolving market demands - ultimately delivering exceptional value and a superior experience to our customers.
Our systems streamline operations by applying organic principles, enhancing workflow agility and efficiency. We operate in accordance with internationally recognized quality standards - including ISO, GACP (Good Agricultural and Collection Practice), GDP (Good Distribution Practice) and GMP (Good Manufacturing Practice) - to ensure the highest levels of reliability, product safety, and sustainability across all areas of our business. These frameworks form the backbone of our commitment to consistent quality, regulatory compliance and continuous improvement.
At CANWAY, innovation drives our mission to create safer, more effective cannabis experiences. We are dedicated to advancing cannabinoid science through rigorous research, technology, and the development of next-generation products. A central focus of our innovation strategy is harm reduction - exploring alternative delivery methods, refining formulations, and designing products that minimize risks while maximizing therapeutic and consumer benefits. Through this approach, we aim to unlock the full potential of the cannabis plant in ways that are responsible, safe and forward-thinking.
Founded in 2016, Green Passion© is one of the first and most reputable CBD brands in Europe. The brand offers a wide range of premium, ready-to-consume hemp-based lifestyle and wellness products, including high-quality smokable items such as CBD flowers, hash, and vapes, as well as cosmetics, healthcare products, foods, and accessories.
Green Passion© products are available at the flagship store on Badenerstrasse 249 in Zurich, online at www.greenpassion.ch, and through selected retail partners.
Green Passion© is a fully owned subsidiary and registered trademark of CANWAY.
CannaBroker is Switzerland’s leading international CBD trading company and one of Europe’s foremost CBD wholesalers. As an integral part of CANWAY Holdings Ltd., CannaBroker operates as the central distribution hub for all non-psychoactive hemp products manufactured within the Group. In addition, it sources premium hemp goods from a trusted network of partners across Europe, Africa, Asia, North America, and South America -delivering them to markets worldwide.
CannaBroker comprises three strategic entities that form a seamlessly integrated global operation: the Swiss headquarters, the EU distribution centre in the Czech Republic, and CannaBroker South Africa (Pty) Ltd. The South African division coordinates greenhouse and outdoor cultivation throughout the region, supporting local farmers with agronomic expertise and ensuring compliance with international standards. By bridging African production with European distribution, it plays a pivotal role in the CANWAY Group’s global supply chain.
Under the Dolocan® brand, a range of Swiss-made cannabis/CBD healthcare products with standardized cannabinoid content is marketed, including skincare, beauty & wellness items, as well as tinctures and oils.
The innovative Dolocan® skincare line represents a new generation of natural wellness and beauty products, focused on holistic well-being. These skincare products support both body and mind in a sustainable way, promoting natural balance in everyday life.
FENOCAN Switzerland LLC, established in 2018, is one of Europe’s leading breeders and producers of feminized hemp seeds with low THC content (<1%).
Under the FENOCAN® brand, the company produces and internationally markets feminized CBD- and CBG-dominant seeds in Switzerland. Its unique portfolio of selected, non-psychoactive F1 hybrid varieties provides both home growers and industrial cultivators with top-quality cannabis seeds - available in all countries where cultivation is legally permitted. All seeds are ISTA certified by the Agroscope seed quality research institute.
The Grow AG, based in Dietlikon (ZH), Switzerland, was founded in 2024 and operates one of Europe’s most advanced indoor facilities for both medical (≥ 1% THC) and non-medical (CBD, < 1% THC) cannabis cultivation. The site spans 3,000 m² and is expandable to 5,000 m².
The company holds a Swissmedic license for medical cannabis cultivation. The facility includes five flowering rooms, two propagation rooms, and two drying rooms. Production follows GACP and ISO 9001 standards (certified by SWISO), with GMP-compliant post-harvest areas. Current capacity is around 3 tonnes of premium indoor flowers annually, scalable to 5 tonnes. The Grow AG employs approximately 9 specialists.
IDEAL Growing AG, based in Fischbach-Göslikon (AG), Switzerland, operates one of the largest indoor facilities for cultivating CBD hemp in Europe. Covering a production area of 3,500 m², the facility grows hemp plants with a THC content below 1% in compliance with GACP guidelines.
The facility was commissioned in 2019 and acquired by the CANWAY Group in 2022. With an annual production capacity of approximately 3.5 tonnes of dried flowers and a team of around 12 employees, the company specializes in the efficient and standardized production of high-quality hemp raw materials. Product distribution is handled exclusively by CannaBroker AG, a member of the group.
Hotsprings Greenhouse (Pty) Ltd was founded in 2024 and operates a large-scale greenhouse facility in Bela-Bela, Limpopo, South Africa, for the cultivation of CBD hemp. Cultivation takes place in two greenhouses, each covering 5,000 m², with an annual production capacity of around 15 tonnes – scalable up to 30 tonnes of premium-quality flowers.
The company cultivates in accordance with GACP guidelines under a hemp license from the South African Department of Agriculture (DALRRD). Currently, only CBD and CBG hemp with low THC content is grown for non-medical purposes. Technical upgrades are underway to enable future medical THC production.
Hotsprings Greenhouse currently employs around 25 people.
PhytoXtract is a Swiss-based pharmaceutical CDMO (Contract Development and Manufacturing Organization) specializing in the production of medical cannabis. Certified by Swissmedic for both GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice), the company operates under mutual recognition with EU-GMP standards. PhytoXtract holds all required licenses for the import, manufacture, and export of plant-based narcotics, with a focus on cannabis flowers and extracts.
Founded in 2016, the company employs around 20 specialized professionals and serves as the exclusive producer for Switzerland’s recreational cannabis pilot projects in Geneva and Lausanne.
In 2024, CANWAY began collaborating with PhytoXtract in the field of medical cannabis manufacturing, supporting the Group’s strategic focus on pharmaceutical-grade production.
For more information, please visit www.phytoxtract.ch.